# A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions

> **NCT02481414** · PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 81 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **BIOLOGICAL:** PepCan
- **BIOLOGICAL:** Candin®

## Key facts

- **NCT ID:** NCT02481414
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-30
- **Primary completion:** 2022-09-14
- **Final completion:** 2022-09-14
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2023-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481414, "A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02481414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*